HLB PANAGENE Co., LTD. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 2,130.00
0.00 (0.00%)
Last updated: Jul 14, 2025
HLB PANAGENE Co., LTD. Company Description
HLB PANAGENE Co., LTD. develops products in the field of molecular diagnostics in South Korea. Its products include liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases.
The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products.
The company was formerly known as Panagene Inc. and changed its name to HLB PANAGENE Co., LTD. in August 2023.
HLB PANAGENE Co., LTD. was incorporated in 1976 and is based in Daejeon, South Korea.
HLB PANAGENE Co., LTD.
| Country | South Korea |
| Founded | 1976 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 81 |
| CEO | Sung-Ki Kim |
Contact Details
Address: 54, Techno 10-ro Daejeon, 34027 South Korea | |
| Phone | 82 4 2861 9295 |
| Website | panagene.com |
Stock Details
| Ticker Symbol | 046210 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Sung-Ki Kim | Chief Executive Officer |